Methods
1) Development of ultrasound examination for precise assessment of the gestational age based on fetal crownrump length (CRL) measure.
2) Development of a real time PCR Taqman® GPCMV based on the amplification of a sequence of the UL83 gene and determination of its sensitivity.
3) Subcutaneous administration at mid-gestation of two doses (10 6 DI50 in group 1 and 10 8 DI50 in group 2 of GPCMV strain obtained by cell culture in CMV-seronegative pregnant Hartley strain guinea pigs. Serial sacrifice of the animals were performed in the second part of the gestation up to collect maternal tissues, maternal blood, amniotic fluid, placenta and fetal tissues and to determine the GPCMV load. Conventional histological examination of the fetal infected tissues was performed.
Results
18 pregnant guinea pigs were included in group 1 and nine in group 2. 1) Ultrasound examinations allowed the diagnosis of gestations in the totality of the cases. A growth curve of fetuses based on CRL was built.
2) The real time PCR GPCMV developed had sensitivity at 50% and 95% of 200 copies/mL and 2500 copies/mL respectively, with a wide linear ranges up to 10 6 copies/ mL.
3) CMV infections were observed in 14/18 females in group1 and in 9/9 females in group 2.
GPCMV maternal viremia was observed in 28% and 70%, the median viral load was 100 and 700 copies/ml in groups 1 and 2 respectively. The proportion of female with at least one infected fetus in their litter was 0/18 and 2/9 (22.22%) in group 1 and 2 respectively (p= 0.103, Fisher Exact Test).
